Publicaciones

PUBLICACIONES DEL PII DE EPID​

  • Personalized medicine in sarcoidosis: unravelling biomarkers for targeted care. Francesqui J, Marrades P, Sellares J. Curr Opin Pulm Med. 2023 Sep 1;29(5):478-484. doi: 10.1097/MCP.0000000000000985. Epub 2023 Jul 6.
  • Benefits of a Homecare Integral Patient Support Program in Idiopathic Pulmonary Fibrosis. Cobo Sanchez L, Ruiz Herrero C, Cobos I, Bespin J, Gadea C, Cerdá-Cortés P, Palma J, Vicens-Zygmunt V, Bermudo G, Portillo K, Boldova A, Robles A, Arribas J, Figuerola JA, Blavia R, Moreno A, Castillo D, Villar A, Belmonte Y, Badenes-Bonet D, Zayas D, Suarez-Cuartin G, Garcia-Bellmunt L, Sellarés J, Barril S, Sans J, Serra M, Perich D, Esteban LL, Esteban L, Balcells E, Gil F, Ruiz E, Fina C, Molina-Molina M. Arch Bronconeumol. 2023 Aug;59(8):526-530. doi: 10.1016/j.arbres.2023.03.008. Epub 2023 Mar 21
  • Validity of prognostic models of critical COVID-19 is variable. A systematic review with external validation. Cárdenas-Fuentes G, Bosch de Basea M, Cobo I, Subirana I, Ceresa M, Famada E, Gimeno-Santos E, Delgado-Ortiz L, Faner R, Molina-Molina M, Agustí À, Muñoz X, Sibila O, Gea J, GarciaAymerich J.J Clin Epidemiol. 2023 Jul;159:274-288. doi: 10.1016/j.jclinepi.2023.04.011. Epub 2023 May 2.
  • Impact of COVID-19 Infection on Patients with Preexisting Interstitial Lung Disease: A Spanish Multicentre Study. Martínez-Besteiro E, MolinaILD-COVID 19 Molina M, Gaeta AM, Aburto M, Casanova Á, Rigual Bobillo J, Orozco S, Pérez Rojo R, Godoy R, López-Muñiz Ballesteros B, Pinillos Robles EJ, Sánchez Fraga S, Peña Miguel T, Balcells E, Laporta R, Rodríguez Portal JA, Herrera Lara S, Cabrera E, Acosta O, Peláez A, Valenzuela C.
  • European Respiratory Society statement on familial pulmonary fibrosis. Borie R, Kannengiesser C, Antoniou K, Bonella F, Crestani B, Fabre A, Froidure A, Galvin L, Griese M, Grutters JC, Molina-Molina M, Poletti V, Prasse A, Renzoni E, van der Smagt J, van Moorsel CHM.Eur Respir J. 2023 Mar 16;61(3):2201383. doi: 10.1183/13993003.01383-2022. Print 2023 Mar.
  • Fine-tuning characterization of patients with interstitial pneumonia and an underlying autoimmune disease in real-world practice: We get closer with Nailfold videocapillaroscopy. Romero-Bueno FI, Rodríguez-Nieto MJ, Palacios Miras C, Martínez Estupiñán L, Martínez-Becerra MJ, Vegas Sánchez MC, Cedeño Díaz OM, Sánchez-Pernaute O; NEREA Autoimmune ILD Study Group. Front Med (Lausanne). 2023 Feb 15;10:1057643. doi: 10.3389/fmed.2023.1057643. eCollection 2023
  • Functional respiratory impairment and related factors in patients with interstitial pneumonia with autoimmune features (IPAF): Multicenter study from NEREA registry. Nieto MA, Sanchez-Pernaute O, Vadillo C, RodriguezNieto MJ, Romero-Bueno F, López-Muñiz B, Cebrian L, Rio-Ramirez MT, Laporta R, Bonilla G, Cobo T, Leon L, Abasolo L; NEREA Group.Respir Res. 2023 Jan 18;24(1):19. doi: 10.1186/s12931-023-02317-5.
  • Predictors and changes of physical activity in idiopathic pulmonary fibrosis. Badenes-Bonet D, Rodó-Pin A, Castillo-Villegas D, Vicens-Zygmunt V, Bermudo G, Hernández-González F, Portillo K, Martínez-Llorens J, Chalela R, Caguana O, Sellarés J, Molina-Molina M, Duran X, Gea J, RodríguezChiaradia DA, Balcells E. BMC Pulm Med. 2022 Sep 9;22(1):340. doi: 10.1186/s12890-022-02134-4. PMID: 36085057 Free PMC article.
  • SARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung sequelae. Cruz T, Mendoza N, Perea L, Albacar N, Gonzalez A, HernandezGonzalez F, Juan M, Agustí A, Sellares J, Sibila O, Faner R. ERJ Open Res. 2022 Mar 7;8(1):00706-2021. doi: 10.1183/23120541.00706-2021. eCollection 2022 Jan. PMID: 35261913 Free PMC article.
  • Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge. Sibila O, Perea L, Albacar N, Moisés J, Cruz T, Mendoza N, Solarat B, Lledó G, Espinosa G, Barberà JA, Badia JR, Agustí A, Sellarés J, Faner R. Respir Res. 2022 Feb 21;23(1):37. doi: 10.1186/s12931-022-01955-5. PMID: 35189887 Free PMC article.
  • The impact of demographic disparities in the presentation of sarcoidosis: A multicenter prospective study. Zhou Y, Gerke AK, Lower EE, Vizel A, Talwar D, Strambu I, Francesqui J, Sellares J, Sawahata M, Obi ON, Nagai S, Tanizawa K, Judson MA, Jeny F, Valeyre D, Cunha Castro MD, Pereira C, Balter M, Baughman RP. Sarco-1 Respir Med. 2021 Oct;187:106564. doi: 10.1016/j.rmed.2021.106564. Epub 2021 Aug 9. PMID: 34391118
  • Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe.Karampitsakos T, Spagnolo P, Mogulkoc N, Wuyts WA, Tomassetti S, Bendstrup E, Molina-Molina M, Manali ED, Unat ÖS, Bonella F, Kahn N, Kolilekas L, Rosi E, Gori L, Ravaglia C, Poletti V, Daniil Z, Prior TS, Papanikolaou IC, Aso S, Tryfon S, Papakosta D, Tzilas V, Balestro E, Papiris S, Antoniou K, Bouros D, Wells A, Kreuter M, Tzouvelekis A.Respirology. 2022 Sep 18. doi: 10.1111/resp.14363. Online ahead of print.PMID: 36117239
  • Harnessing PM2.5 Exposure Data to Predict Progression of Fibrotic Interstitial Lung Diseases Based on Telomere Length. Shull JG, Planas-Cerezales L, Lara Compte C, Perona R, Molina-Molina M. Front Med (Lausanne). 2022 May 12;9:871898. doi: 10.3389/fmed.2022.871898. eCollection 2022. PMID: 35646972 Free PMC article.
  • Evidence for shared genetic risk factors between lymphangioleiomyomatosis and pulmonary function. Farré X, Espín R, Baiges A, Blommaert E, Kim W, Giannikou K, Herranz C, Román A, Sáez B, Casanova Á, Ancochea J, Valenzuela C, Ussetti P, Laporta R, Rodríguez-Portal JA, van Moorsel CHM, van der Vis JJ, Quanjel MJR, TenaGaritaonaindia M, Sánchez de Medina F, Mateo F, Molina-Molina M, Won S, Kwiatkowski DJ, de Cid R, Pujana MA. ERJ Open Res. 2022 Jan 24;8(1):00375-2021. doi: 10.1183/23120541.00375- 2021. eCollection 2022 Jan. PMID: 35083324 Free PMC article.
  • Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology. EPIDEAS Fecha y firma del Director del PII: 17/10/2022 Narváez J, Aburto M, Seoane-Mato D, Bonilla G, Acosta O, Candelas G, CanoJiménez E, Castellví I, González-Ruiz JM, Corominas H, López-Muñiz B, Martín-López M, Robles-Pérez A, Mena-Vázquez N, Rodríguez-Portal JA, Ortiz AM, Sabater-Abad C, Castrejón I, Dos Santos R, Garrote-Corral S, Maese J, Silva-Fernández L, Castañeda S, Valenzuela C. Reumatol Clin (Engl Ed). 2022 Jun 23:S2173-5743(22)00095-8. doi: 10.1016/j.reumae.2021.12.003. Online ahead of print. PMID: 35753951 Free article.
  • Bermudo G, Suarez-Cuartin G, Rivera-Ortega P, Rodriguez-Portal JA, Sauleda J, Nuñez B, Castillo D, Aburto M, Portillo K, Balcells E, Badenes-Bonet D, Valenzuela C, Fernandez-Fabrellas E, González-Budiño T, Cano E, Acosta O, Leiro-Fernández V, Romero A, Planas-Cerezales L, Villar A, Moreno A, Laporta R, Vicens-Zygmunt V, Shull J, Franquet T, Luburich P, Molina-Molina M.  Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity. Arch Bronconeumol (Engl Ed). 2021 Mar 27;S0300-2896(21)00116-2
  • Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis.  Cano-Jiménez E, Vázquez Rodríguez T, Martín-Robles I, Castillo Villegas D, Juan García J, Bollo de Miguel E, Robles-Pérez A, Ferrer Galván M, Mouronte Roibas C, Herrera Lara S, Bermudo G, García Moyano M, Rodríguez Portal JA, Sellarés Torres J, Narváez J, Molina-Molina M.  Sci Rep. 2021 Apr 28;11(1):9184.
  • Kalluri M, Luppi F, Vancheri A, Vancheri C, Balestro E, Varone F, Mogulkoc N, Cacopardo G, Bargagli E, Renzoni E, Torrisi S, Calvello M, Libra A, Pavone M, Bonella F, Cottin V, Valenzuela C, Wijsenbeek M, Bendstrup E; 3rd International Summit for ILD (ISILD), Erice collaborators listed below.  Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?  Eur Respir Rev. 2021 May 25;30(160):210026. (M. Molina, D. Castilo Erice Collaborators)
  • Espín R, Baiges A, Blommaert E, Herranz C, Roman A, Saez B, Ancochea J, Valenzuela C, Ussetti P, Laporta R, Rodríguez-Portal JA, van Moorsel CHM, van der Vis JJ, Quanjel MJR, Villar-Piqué A, Diaz-Lucena D, Llorens F, Casanova Á, Molina-Molina M, Plass M, Mateo F, Moss J, Pujana MA.  Heterogeneity and Cancer-Related Features in Lymphangioleiomyomatosis Cells and Tissue  Mol Cancer Res. 2021 Jul 26.
  • Herranz C, Mateo F, Baiges A, Ruiz de Garibay G, Junza A, Johnson SR, Miller S, García N, Capellades J, Gómez A, Vidal A, Palomero L, Espín R, Extremera AI, Blommaert E, Revilla-López E, Saez B, Gómez-Ollés S, Ancochea J, Valenzuela C, Alonso T, Ussetti P, Laporta R, Xaubet A, Rodríguez-Portal JA, Montes-Worboys A, Machahua C, Bordas J, Menendez JA, Cruzado JM, Guiteras R, Bontoux C, La Motta C, Noguera-Castells A, Mancino M, Lastra E, Rigo-Bonnin R, Perales JC, Viñals F, Lahiguera A, Zhang X, Cuadras D, van Moorsel CHM, van der Vis JJ, Quanjel MJR, Filippakis H, Hakem R, Gorrini C, Ferrer M, Ugun-Klusek A, Billett E, Radzikowska E, Casanova Á, Molina-Molina M, Roman A, Yanes O, Pujana MA.  Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis.  EMBO Mol Med 2021 Sep 7;13(9):e13929.
  • Planas-Cerezales L, Arias-Salgado EG, Berastegui C, Montes-Worboys A, González-Montelongo R, Lorenzo-Salazar JM, Vicens-Zygmunt V, Garcia-Moyano M, Dorca J, Flores C, Perona R, Román A, Molina-Molina M. Lung Transplant Improves Survival and Quality of Life Regardless of Telomere Dysfunction.  Front Med (Lausanne). 2021 Jul 30;8:695919Planas-Cerezales L, Arias-Salgado EG, Berastegui C, Montes-Worboys A, González-Montelongo R, Lorenzo-Salazar JM, Vicens-Zygmunt V, Garcia-Moyano M, Dorca J, Flores C, Perona R, Román A, Molina-Molina M. Lung Transplant Improves Survival and Quality of Life Regardless of Telomere Dysfunction.  Front Med (Lausanne). 2021 Jul 30;8:695919
  • Zhou Y, Gerke AK, Lower EE, Vizel A, Talwar D, Strambu I, Francesqui J, Sellares J, Sawahata M, Obi ON, Nagai S, Tanizawa K, Judson MA, Jeny F, Valeyre D, Cunha Castro MD, Pereira C, Balter M, Baughman RP. The impact of demographic disparities in the presentation of sarcoidosis: A multicenter prospective study. Respir Med. 2021 Aug 9;187:106564.
  • Baughman RP, Lower EE, Buchanan M, Rottoli P, Drent M, Sellares J, Terwiel M, Elfferich M, Francesqui J, Barriuso Cabrerizo MR, Sweiss N, Martone F, Al-Hakim T, Judson MA. Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(4):e2020009.
  • Shull JG, Pay MT, Lara Compte C, Olid M, Bermudo G, Portillo K, Sellarés J, Balcells E, Vicens-Zygmunt V, Planas-Cerezales L, Badenes-Bonet D, Blavia R, Rivera-Ortega P, Moreno A, Sans J, Perich D, Barril S, Esteban L, Garcia-Bellmunt L, Esplugas J, Suarez-Cuartin G, Bordas-Martinez J, Castillo D, Jolis R, Salvador I, Eizaguirre Anton S, Villar A, Robles-Perez A, Cardona MJ, Barbeta E, Silveira MG, Guevara C, Dorca J, Rosell A, Luburich P, Llatjós R, Jorba O, Molina-Molina M.  Mapping IPF helps identify geographic regions at higher risk for disease development and potential triggers.  Respirology. 2021 Apr;26(4):352-359. doi: 10.1111/resp.13973. Epub 2020 Nov 9Baughman RP, Lower EE, Buchanan M, Rottoli P, Drent M, Sellares J, Terwiel M, Elfferich M, Francesqui J, Barriuso Cabrerizo MR, Sweiss N, Martone F, Al-Hakim T, Judson MA. Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(4):e2020009
  • Castillo D, Sánchez-Font A, Pajares V, Franquet T, Llatjós R, Sansano I, Sellarés J, Centeno C, Fibla JJ, Sánchez M, Ramírez J, Moreno A, Trujillo-Reyes JC, Barbeta E, Molina-Molina M, Torrego A. A multidisciplinary proposal for a diagnostic algorithm in idiopathic pulmonary fibrosis: the role of transbronchial cryobiopsy. Arch Bronconeumol. 2020;56:99-105 Q1.

    Kreuter M, Polke M, Walsh SLF, Krisam J, Collard HR, Chaudhuri N, Avdeev S, Behr J, Calligaro G, Corte T, Flaherty K, Funke-Chambour M, Kolb M, Kondoh Y, Maher TM, Molina Molina M, Morais A, Moor CC, Morisset J, Pereira C, Quadrelli S, Selman M, Tzouvelekis A, Valenzuela C, Vancheri C, Vicens-Zygmunt V, Wälscher J, Wuyts W, Wijsenbeek M, Cottin V, Bendstrup E. Acute exacerbaation of idiopathic pulmonary fibrosis: international survey and a call for harmonisation. Eur Respir J. 2020;55(4):1901760. D1

  • Drake TM, Docherty AB, Harrison EM, Quint JK, Adamali H, Agnew S, Babu S, Barber CM, Barratt S, Bendstrup E, Bianchi S, Castillo Villegas D, Chaudhuri N, Chua F, Coker R, Chang W, Crowley LE, Dosanjh D, Fiddler CA, Forrest IA, George PM, Gibbons MA, Groom K, Haney S, Hart SP, Heiden E, Henry M, Ho LP, Hoyles RK, Hutchinson J, Hurley K, Jones MG, Jones S, Kokosi M, Kreuter M, Mackay LS, Mahendran S, Margaritopoulos G, Molina-Molina M, Molyneaux PL, O'Brien A, O'Reilly K, Packham A, Parfrey H, Poletti V, Porter JC, Renzoni E, Rivera-Ortega P, Russell AM, Saini G, Spencer LG, Stella GM, Stone H, Sturney S, Thickett D, Thillai M, Wallis T, Ward K, Wells AU, West A, Wickremasinghe M, Woodhead F, Hearson G, Howard L, Baillie JK, Openshaw PJM, Semple MG, Stewart I, Jenkins RG; ISARIC4C Investigators. Outcome of hospitalaization for COVID19 in patients with ILD: an international multicenter study. Am J Respir Crit Care Med. 2020 Oct 2. D1
  • Allen RJ, Guillen-Guio B, Oldham JM, Ma SF, Dressen A, Paynton ML, Kraven LM, Obeidat M, Li X, Ng M, Braybrooke R, Molina-Molina M, Hobbs BD, Putman RK, Sakornsakolpat P, Booth HL, Fahy WA, Hart SP, Hill MR, Hirani N, Hubbard RB, McAnulty RJ, Millar AB, Navaratnam V, Oballa E, Parfrey H, Saini G, Whyte MKB, Zhang Y, Kaminski N, Adegunsoye A, Strek ME, Neighbors M, Sheng XR, Gudmundsson G, Gudnason V, Hatabu H, Lederer DJ, Manichaikul A, Newell JD Jr, Bossé Y, Hao K, Joubert P, Nickle DC, Sin DD, Timens W, Furniss D, Morris AP, Zondervan KT, Hall IP, Sayers I, Tobin MD, Maher TM, Cho MH, Hunninghake GM, Schwartz DA, Yaspan BL, Molyneaux PL, Flores C, Noth I, Jenkins RG, Wain LV. Genome-wide association study of susceptibility to idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2020;201:564-574   D1
  • Salvador-Corres I, Quirant-Sanchez B, Teniente-Serra A, Centeno C, Moreno A, Rodríguez-Pons L, Serra-Mitjá P, García-Nuñez M, Martinez-Caceres M, Rosell A, Olivé A, Portillo K. Detection of autoantiboides in bronchoalveolar lavage in patients with diffuse interstitial lung disease. Arch Bronconeumol. 2020;S0300-2896(20)30303-3
  • Wells AU et al (3 investigadores PII EPID de diferentes centros: C. Valenzuela, JA. Rodriguez-Portal, M. Molina-Molina). Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomized, double-blind, placebo-controlled, parallel-group trial. Lancet Respir Med. 2020;8(5):453-460 D1
  • George PM, Spagnolo P, Kreuter M, Altinisik G, Bonifazi M, Martinez FJ, Molyneaux PL, Renzoni EA, Richeldi L, Tomassetti S, Valenzuela C, Vancheri C, Varone F, Cottin V, Costabel U; Erice ILD working group. Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities. Lancet Respir. Med. 2020;8:925-34 D1. (Erice ILD working group se compone de 3 miembros o representantes del PII EPID: C. Valenzuela, D. Castillo, M. Molina-Molina)
  • Robles-Pérez A, Luburich P, Bolivar S, Dorca J, Nolla JM, Molina-Molina M, Narváez J. A prospective study of lung disease in a cohort of early rheumatoid arthritis patients. Sci Rep. 2020;10:15640. Q1
  • Sellarés J, Molina-Molina M. Serum biomarkers in diffuse interstitial lung diseases. Arch Bronconeumol. 2020;56(6):349-50. Q1
  • Molina-Molina M. The future of pharmacological treatment in IPF. Ach. Bronconeumol. 2019. Epub ahead of print
  • Fernández-Fabrellas E, Molina-Molina M, Soriano JB, Portal JAR, Ancochea J, Valenzuela C, Xaubet A. Demographic and clinical profile of IPF in Spain: SEPAR National Registry. Respir Res. 2019; 20:127
  • Moore C, et al (3 autores del PII EPID). Resequencing study confirms that host defense and cell senescence gene variants contribute to the risk of IPF. Am J Respir Crit Care Med. 2019;200:199-208
  • Arias-Salgado EG, Galvez E, Planas-Cerezales L, Pintado-Berninches L, Vallespin E, Martinez P, Carrillo J, Iarriccio L, Ruiz-LLobet A, Catalá A, BadellSerra J, Gonzalez-Granado LI, Martín-Nalda A, Martinez-Gaallo M, GaleraMiñarro Aa, Rodríguez-Vigil C, Bastos-Oreiro M, Perez de Nanclares G, LeiroFernandez V, Uria ML, Diaz-Heredia C, Valenzuela C, Martín S, López-Muñiz B, Lapunzina P, Sevilla J, Molina-Molina M, Perona R, Sastre L. Genetic analyses of aplastic anaemia and idiopathic pulmonary fibrosis patients with short telomeres, possible implication of DNA-repair genes. Orphanet J Rare Dis. 2019. Epub ahead of print.
  • Martínez González C, Prieto-González A, García Alfonso L, Fernández Fernández L, Moreda Bernardo A, Fernandez Alvarez R, Rolle-Sóñora V, Ruano Raviña A, Casan Clarà P. Silicosis in artificial quartz conglomerate workers. Arch Bronconeumol. 2019:55:459-64.
  • Cottin V, Annesi-Maesano I, Günther A, Galvin L, Kreuter M, Powell P, Prasse A, Reynolds G, Richeldi L, Spagnolo P, Valenzuela C, Wijsenbeek M, Wuyts WA, Crestani B, Ariane-IPF Clinical Research Collaboration Consortium. The Ariane-IPF ERS clinical research collaboration: seeking collaboration through launch of a federation of European registries on idiopathic pulmonary fibrosis. Eur Respir J. 2019;53
  • Kreuter M, Lederer DJ, Molina-Molina M, Noth I, Valenzuela C, Frankenstein L, Weycker D, Atwood M, Kirchgaessler KU, Cottin V. Association of angiotensin modulators with the course of idiopathic pulmonary fibrosis. Chest. 2019;156:706-14.
  • Guenther A, Krauss E, Tello S, Wagner J, Paul B, Kuhn S, Maurer O, Heinemann S, Costabel U, Nieto-Barbero MA, Müller V, Bonniaud P, Vancheri C, Wells A, Vasakova M, Pesci A, Sofia M, Klepetko W, Seeger W, Drakopanagiotakis F, Crestani B. The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis. Respir Res. 2018;19(1):141
  • Castillo D, Walsh S, Hansell DM, Vasakova M, Cottin V, Altinisik G, Palmucci S, Sterclova M, Harari S, Richeldi L, Vancheri C, Wells AU; ERICE ILD working group. Lancet Respir Med. 2018;6(2):88-89.
  • Planas-Cerezales L, Arias-Salgado EG, Buendia-Roldán I, Montes-Worboys A, López CE, Vicens Zygmunt V, Luburich P, Llatjós R, Leiro-Fernandez V, Balcells E, Sala E, Sargatal JD, Perona R, Selman M, Molina-Molina M. Predictive factors and prognostic effect of telomere shortening in pulmonary fibrosis. Respirology. 2018 .
  • Galán-Cobo A, Arellano-Orden E, Sánchez Silva R, López-Campos JL, Gutiérrez Rivera C, Gómez Izquierdo L, Suárez-Luna N, Molina-Molina M, Rodríguez Portal JA, Echevarría M. The Expression of AQP1 IS Modified in Lung of Patients With Idiopathic Pulmonary Fibrosis: Addressing a Possible New Target. Front Mol Biosci. 2018;5:43
  • Molina-Molina M, Aburto M, Acosta O, Ancochea J, Rodríguez-Portal JA, Sauleda J, Lines C, Xaubet A. Importance FPI leve countries. BMC Pulm Med. 2017 Sep 15;17(1):124 Xaubet A, Molina-Molina M, Acosta O, Bollo E, Castillo D, FernándezFabrellas E, Rodríguez-Portal JA, Valenzuela C, Ancochea J. Guidelines for the medical treatment of idiopathic pulmonary fibrosis. Arch Bronconeumol. 2017;53(5):263-269. Registro FPI. FPI LEVE Johannson KA, Strâmbu I, Ravaglia C, Grutters JC, Valenzuela C, Mogulkoc N, Luppi F, Richeldi L, Wells AU, Vancheri C, Kreuter M; Erice ILD Working Group. Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers? Lancet Respir Med. 2017 Jul;5(7):591-598 Registro FPI Xaubet A, Ancochea J, Molina-Molina M. Idiopathic pulmonary fibrosis. Med Clin (Barc). 2017;148(4):170-175. Registro of early diagnosis and treatment in idiopathic pulmonary fibrosis. Expert Rev Respir Med. 2018;12:537-539
  • Molina-Molina M, Planas-Cerezales L, Perona R. Telomere Shortening in Idiopathic Pulmonary Fibrosis. Arch Bronconeumol. 2018;54(1):3-4.
  • Portillo K, Perez-Rodas N, García-Olivé I, Guasch-Arriaga I, Centeno C, Serra P, Becker-Lejuez C, Sanz-Santos J, Andreo García F, Ruiz-Manzano J. Lung Cancer in Patients With Combined Pulmonary Fibrosis and Emphysema and Idiopathic Pulmonary Fibrosis. A Descriptive Study in a Spanish Series. Arch Bronconeumol. 2017;53(6):304-310
  • Millan-Billi P, Serra C, Alonso Leon A, Castillo D. Comorbidities, Complications and Non-Pharmacologic Treatment in Idiopathic Pulmonary Fibrosis. Med Sci (Basel). 2018;6(3)
  • Valenzuela C, Cottin V, Ancochea J. Interstitial pneumonia with autoimmune features: An update. Arch Bronconeumol. 2018;54(9):447-448.
  • Yoon JH, Nouraie M, Chen X, Zou RH, Sellares J, Veraldi KL, Chiarchiaro J, Lindell K, Wilson DO, Kaminski N, Burns T, Trejo Bittar H, Yousem S, Gibson K, Kass DJ. Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease - analysis of institutional and population data. Respir Res. 2018;19(1):195
  • Barril S, Alonso A, Rodríguez-Portal JA, Viladot M, Giner J, Aparicio F, Romero-Ortiz A, Acosta O, Castillo D. Palliative Care in Diffuse Interstitial Lund Disease: Results of a Spanish Survey. Arch Bronconeumol. 2018;54(3):123-127
  • Gabasa M, Duch P, Jorba I, Giménez A, Lugo R, Pavelescu I, RodríguezPascual F, Molina-Molina M, Xaubet A, Pereda J, Alcaraz J. Epithelial contribution to the pro-fibrotic stiff microenvironment and myofibroblast population in lung fibrosis. Mol Biol Cell. 2017
  • Molina-Molina M, Planas-Cerezales L, Perona R. Telomere Shortening in Idiopathic Pulmonary Fibrosis. Arch Bronconeumol. 2017
  • Maher TM, Molina-Molina M, Russell AM, Bonella F, Jouneau S, Ripamonti E, Axmann J, Vancheri C. Unmet needs in the treatment of idiopathic pulmonary fibrosis-insights from patient chart review in five European countries. BMC Pulm Med. 2017 Sep 15;17(1):124
  • Xaubet A, Molina-Molina M, Acosta O, Bollo E, Castillo D, FernándezFabrellas E, Rodríguez-Portal JA, Valenzuela C, Ancochea J. Guidelines for the medical treatment of idiopathic pulmonary fibrosis. Arch Bronconeumol. 2017;53(5):263-269
  • Johannson KA, Strâmbu I, Ravaglia C, Grutters JC, Valenzuela C, Mogulkoc N, Luppi F, Richeldi L, Wells AU, Vancheri C, Kreuter M; Erice ILD Working Group. Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers? Lancet Respir Med. 2017 Jul;5(7):591-598
  • Xaubet A, Ancochea J, Molina-Molina M. Idiopathic pulmonary fibrosis. Med Clin (Barc). 2017;148(4):170-175.
  • Serrano-Mollar, Gay-Jordi G, Guillamat-Prats R, Closa D, Hernandez-Gonzalez F, Marin P, Burgos F, Martorell J, Sanchez M, Arguis P, Soy D, Bayas JM, Ramirez J , Tetley, TD, Molins L, Puig de la Bellacasa J, Rodriguez-Villar C, Rovira I, Fiblà JJ, Xaubet A. Safety and Tolerability of Alveolar Type II Cell Transplantation in Idiopathic Pulmonary Fibrosis. Chest. 2016. 150(3):533-43
  • Nuñez O, Román A, Johnson SR, Inoue Y, Hirose M, Casanova A, de Garibay GR, Herranz C, Bueno-Moreno G, Boni J, Mateo F, Petit A, Climent F, Soler T, Vidal A, Sánchez-Mut JV, Esteller M, López JI, Garcia N, Gumà A, Ortega R, Plà MJ, Campos M, Ansótegui E, Molina-Molina M, Valenzuela C Usetti P, Laporta R, Ancochea J, Xabet A, Pollán M, Pujana MA. Study of breast cancer incidence in patients of lymphangioleiomyomatosis. Breast Cancer Res. Treat. 2016;156(1):195-201.
  • Diez-Ferrer M, Luburich P, Llatjós R, Xaubet A, Dorca J, Molina-Molina M. Dendriform Pulmonary Ossification in a Subclinical Case of Familial Pulmonary Fibrosis. Arch Bronconeumol. 2016. pii: S0300-2896(16)30133-8.
  • Bonella F, Wijsenbeek M, Molina-Molina M, Duck A, Mele R, Geissler K, Wuyts W. European idiopathic pulmonary fibrosis Patient Charter: a missed opportunity. Eur Respir J. 2016;48(1):283-4.
  • Robles-Perez A, Luburich P, Rodriguez-Sanchon B, Dorca J, Nolla JM, Molina-Molina M, Narvaez-Garcia J. Preclinical lung disease in early rheumatoid arthritis. Chron Respir Dis. 2016;13(1):75-81.
  • Casan Clarà P, Martínez González C, Ancochea J. Lung function testing in idiopathic pulmonary fibrosis: More than just spirometry? Arch Bronconeumol. 2016;52(9):457-8
  • Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness. Ruiz de Garibay G, Herranz C, Llorente A, Boni J, Serra-Musach J, Mateo F, Aguilar H, Gómez-Baldó L, Petit A, Vidal A, Climent F, Hernández-Losa J, Cordero Á, González-Suárez E, Sánchez-Mut JV, Esteller M, Llatjós R, Varela M, López JI, García N, Extremera AI, Gumà A, Ortega R, Plà MJ, Fernández A, Pernas S, Falo C, Morilla I, Campos M, Gil M, Román A, Molina-Molina M, Ussetti P, Laporta R, Valenzuela C, Ancochea J, Xaubet A, Casanova Á, Pujana MA.
  • Robles-Perez A, Molina-Molina M. Respiration. Treatment considerations of lung involvement in Rheumatologic disease. 2015 Oct;90(4):265-74.
  • Vicens-Zygmunt V, Estany S, Colom A, Montes-Worboys A, Machahua C, Sanabria AJ, Llatjos R, Escobar I, Manresa F, Dorca J, Navajas D, Alcaraz J, Molina-Molina M. Fibroblast viability and phenotypic changes within glycated stiffened three-dimensional collagen matrices. Respir Res. 2015 Jul 1;16:82
  • Hernandez-Gonzalez F, Xaubet A, Sellarés J. Keratinolytic Fungi in the Feather Stuffing of a sofá: A rare Cause of Hypersensitive Pneumonitis. Arch Bronconeumol. 2015 Sep;51(9):474-475
  • Hernández-González F, Lucena CM, Ramírez J, Sánchez M, Jimenez MJ, Xaubet A, Sellares J, Agustí C. Cryobiopsy in the diagnosis of diffuse interstitial lung disease: yield and cost-effectiveness analysis. Arch Bronconeumol. 2015 Jun;51(6):261-7
  • Rodríguez Portal JA. Treatment of adult Primary Alveolar Proteinosis. Arch Bronconeumol. 2015 Jul;51(7):344-9.
  • Ferrer Galván M, Rodríguez Portal JA, Serrano Gorarredona MP, Gómez Izquierdo L. Fibrosing mediastinitis mimicking sarcoidosis. Clin Respir J. 2015 Jan;9(1):125-8
  • Drug-induced pneumonitis in cancer patients treated with mTOR inhibitors: management and insights into possible mechanisms. Duran I, Goebell PJ, Papazisis K, Ravaud A, Weichhart T, Rodriguez-Portal JA, Budde K. Expert Opin Drug Saf. 2014 Mar;13(3):361-72. doi: 10.1517/14740338.2014.888056. Epub 2014 Feb 11.
  • Tubers from patients with tuberous sclerosis complex are characterized by changes in microtubule biology through ROCK2 signalling. Ferrer I, Mohan P, Chen H, Castellsague J, Gómez-Baldó L, Carmona M, García N, Aguilar H, Jiang J, Skowron M, Nellist M, Ampuero I, Russi A, Lázaro C, Maxwell CA, Pujana MA. J Pathol. 2014 Jul;233(3):247-57. doi: 10.1002/path.4343. Epub 2014 Apr 29.
  • Diagnostic yield of specific inhalation challenge in hypersensitivity pneumonitis. Muñoz X, Sánchez-Ortiz M, Torres F, Villar A, Morell F, Cruz MJ. Eur Respir J. 2014 Aug 19. pii: erj00607-2014.
  • Bronchial inflammation in hypersensitivity pneumonitis after antigen-specific inhalation challenge. Villar A, Muñoz X, Sanchez-Vidaurre S, Gómez-Ollés S, Morell F, Cruz MJ. Respirology. 2014 Aug;19(6):891-9. doi: 10.1111/resp.12323. Epub 2014 May 29.
  • Adult pulmonary Langerhans' cell histiocytosis: Approach to the reality of the Spanish population. Castillo D, Martin-Arroyo I, Moreno A, Balcells E, Villar A, Vicens-Zygmunt V, Vendrell M, Belda S, Portillo K, Kettou D, Aparicio F, Molina-Molina M; en nombre del grupo CRAMPID. Med Clin (Barc). 2014 Apr 9. pii: S0025-7753(14)00164-X. doi: 10.1016/j.medcli.2013.11.039.
  • Pirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse events. Costabel U, Bendstrup E, Cottin V, Dewint P, Egan JJ, Ferguson J, Groves R, Hellström PM, Kreuter M, Maher TM, Molina-Molina M, Nordlind K, Sarafidis A, Vancheri C. Adv Ther. 2014 Apr;31(4):375-91. doi: 10.1007/s12325-014-0112-1. Epub 2014 Mar 18. Erratum in: Adv Ther. 2014 May;31(5):575-6.
  • Review of IPF diagnosis and management recommendations in Europe. Xaubet A, Behr J, Bendstrup E, Cottin V, Hirani N, Kähler C, Sköld M. Sarcoidosis Vasc Diffuse Lung Dis. 2013 Dec 17;30(4):249-61.
  • Oxygen diffusion and consumption in extracellular matrix gels: implications for designing three-dimensional cultures. Colom A, Galgoczy R, Almendros I, Xaubet A, Farré R, Alcaraz J. J Biomed Mater Res A. 2014 Aug;102(8):2776-84. doi: 10.1002/jbm.a.34946. Epub 2013 Sep 30.
  • Alveolar type II cell transplantation restores pulmonary surfactant protein levels in lung fibrosis. Guillamat-Prats R, Gay-Jordi G, Xaubet A, Peinado VI, Serrano-Mollar A. J Heart Lung Transplant. 2014 Jul;33(7):758-65. doi: 10.1016/j.healun.2014.03.008. Epub 2014 May 17.
  • Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1. Estany S, Vicens-Zygmunt V, Llatjós R, Montes A, Penín R, Escobar I, Xaubet A, Santos S, Manresa F, Dorca J, Molina-Molina M. BMC Pulm Med. 2014 Jul 26;14:120. doi: 10.1186/1471-2466-14-120
  • Pirfenidone for the treatment of idiopathic pulmonary fibrosis. Xaubet A, Serrano-Mollar A, Ancochea J. Expert Opin Pharmacother. 2014 Feb;15(2):275-81. doi: 10.1517/14656566.2014.867328. Epub 2013 Dec 6.
  • Idiopathic pulmonary fibrosis: A challenge for primary care. Molina J, Trigueros JA, Quintano JA, Mascarós E, Xaubet A, Ancochea J. Semergen. 2014 Apr;40(3):134-42. doi: 10.1016/j.semerg.2014.02.001. Epub 2014 Mar 30.
  • Early diagnosis of idiopathic pulmonary fibrosis. Ancochea J, Xaubet A. Semergen. 2014 Apr;40(3):119-20. doi: 10.1016/j.semerg.2014.03.002.
  • Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, SchlenkerHerceg R, Disse B, Collard HR; INPULSIS Trial Investigators. N Engl J Med. 2014 May 29;370(22):2071-82. doi: 10.1056/NEJMoa1402584. Epub 2014 May 18.
  • Indoor air contaminants and their impact on respiratory pathologies. Carazo Fernández L, Fernández Alvarez R, González-Barcala FJ, Rodríguez Portal JA. Arch Bronconeumol. 2013 Jan;49(1):22-7. doi: 10.1016/j.arbres.2012.04.005. Epub 2012 Jun 15. Review
  • Asbestos-related disease: screening and diagnosis. Rodríguez Portal JA. Adv Clin Chem. 2012;57:163-85. Review.
  • The Spanish Lung Transplant Registry: first report of results (2006-2010). Coll E, Santos F, Ussetti P, Canela M, Borro JM, De La Torre M, Varela A, Zurbano F, Mons R, Morales P, Pastor J, Salvatierra A, de Pablo A, Gámez P, Moreno A, Solé J, Román A. Arch Bronconeumol. 2013 Feb;49(2):70-8. doi: 10.1016/j.arbres.2012.06.001. Epub 2012 Aug 28
  • Recommendations on the use of everolimus in lung transplantation. de Pablo A, Santos F, Solé A, Borro JM, Cifrian JM, Laporta R, Monforte V, Román A, de la Torre M, Ussetti P, Zurbano F. Transplant Rev (Orlando). 2013 Jan;27(1):9-16. doi: 10.1016/j.trre.2012.11.001. Epub 2012 Dec 28. Review.
  • Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactante. Monforte V, López-Sánchez A, Zurbano F, Ussetti P, Solé A, Casals C, Cifrian J, de Pablos A, Bravo C, Román A. J Heart Lung Transplant. 2013 Mar;32(3):313-9. doi: 10.1016/j.healun.2012.11.013. Epub 2013 Jan 16.
  • Idiopathic pulmonary fibrosis: importance of accurate diagnosis and treatment. Morell F. Arch Bronconeumol. 2013 Aug;49(8):319-20. doi: 10.1016/j.arbres.2013.04.010. Epub 2013 Jun 18
  • Cell cycle dependence of ACE-2 explains downregulation in idiopathic pulmonary fibrosis. Uhal BD, Dang M, Dang V, Llatos R, Cano E, Abdul-Hafez A, Markey J, Piasecki CC, Molina-Molina M. Eur Respir J. 2013 Jul;42(1):198-210. doi: 10.1183/09031936.00015612. Epub 2012 Oct 25.
  • Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. Raghu G, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Nathan SD, Wells AU, Collard HR, Costabel U, Richeldi L, de Andrade J, Khalil N, Morrison LD, Lederer DJ, Shao L, Li X, Pedersen PS, Montgomery AB, Chien JW, O'Riordan TG; ARTEMIS-IPF Investigators*. Ann Intern Med. 2013 May 7;158(9):641-9. doi: 10.7326/0003-4819-158-9-201305070-00003.
  • Angiotensinogen promoter polymorphisms predict low diffusing capacity in U.S. and Spanish IPF cohorts. Dang MT, Gu C, Klavanian JI, Jernigan KA, Friderici KH, Cui Y, Molina-Molina M, Ancochea J, Xaubet A, Uhal BD. Lung. 2013 Aug;191(4):353- 60. doi: 10.1007/s00408-013-9476-2. Epub 2013 May 30.
  • Role of tetrahydrobiopterin in pulmonary vascular remodelling associated with pulmonary fibrosis. Almudéver P, Milara J, De Diego A, Serrano-Mollar A, Xaubet A, Perez-Vizcaino F, Cogolludo A, Cortijo J. Thorax. 2013 Oct;68(10):938-48. doi: 10.1136/thoraxjnl-2013-203408. Epub 2013 Jun 5.
  • Guidelines for the diagnosis and treatment of idiopathic pulmonary fibrosis. Xaubet A, Ancochea J, Bollo E, Fernández-Fabrellas E, Franquet T, Molina-Molina M, Montero MA, Serrano-Mollar A. Arch Bronconeumol. 2013 Aug;49(8):343-53. doi: 10.1016/j.arbres.2013.03.011. Epub 2013 Jun 4.
  • Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2. Gabasa M, Royo D, Molina-Molina M, RocaFerrer J, Pujols L, Picado C, Xaubet A, Pereda J. PLoS One. 2013 Jun 4 3;8(6):e65445. doi: 10.1371/journal.pone.0065445. Print 2013.
  • A haplotype of cyclooxygenase-2 gene is associated with idiopathic pulmonary fibrosis. Xaubet A, Fu WJ, Li M, Serrano-Mollar A, Ancochea J, Molina-Molina M, Rodriguez-Becerra E, Morell F, Rodríguez-Arias JM, Pereda J, Casanova A, Molins L, Picado C. Sarcoidosis Vasc Diffuse Lung Dis. 2010 Jul;27(2):121-30
  • Lymphangioleiomyomatosis treatment with sirolimus. Casanova A, María Girón R, Acosta O, Barrón M, Valenzuela C, Ancochea J. Arch Bronconeumol. 2011 Sep;47(9):470-2. Epub 2011 Mar 25. English, Spanish.
  • An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Müller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schünemann HJ; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
  • Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, King TE Jr, Lancaster L, Sahn SA, Szwarcberg J, Valeyre D, du Bois RM; CAPACITY Study Group. Lancet. 2011 May 21;377(9779):1760-9. Epub 2011 May 13
  • Lymphangioleiomyomatosis: New Therapeutic Approaches. Casanova A, Ancochea J. Arch Bronconeumol. 2011 Sep 14. [Epub ahead of print] English, Spanish. No abstract available.
  • E Cano-Jiménez, M Molina-Molina, M Gabasa, J Ancochea,, M Sánchez, J Ramírez, A Serrano-Mollar, BD Uhal, A Xaubet. Association of transforming growth factor beta-1 angiotensinogen gene polymorphisms influences idiopathic pulmonary fibrosis disease progression. European Respiratory Journal 2010; 34 Suppl 54: P4176.
  • A Xaubet, A Serrano-Mollar, J Ancochea, M Molina-Molina, E Rodriguez-Becerra, F Morell, J Ml Rodríguez-Arias, J Pereda , A Casanova, L Molins , C Picado. A haplotype of Cyclooxygenase-2 gene is associated with idiopathic pulmonary fibrosis. Resp Res; 2010; 27: 121-130.  
  • J Fibla, L Molins, A Blanco, I Royo, P Martínez, N Martínez, A Arnau, S García, A Gómez, E Canalis, M Estors, M Moldes, E Fernández, A Carvajal, P Leon, P Rodriguez, J Freixinet Prospective multicentric study to evaluate the role of video-assisted thoracoscopic lung biopsy in the diagnosis of interstitial lung disease: Evolving concepts. European Respiratory Journal 2010; 34 Suppl 54: P809.
  • A Díaz-Baquero, JL López-Campos, D Rodriguez-Rodriguez, E Arellano-Orden, A Montes-Worboys, I Alfageme-Michavilla, E Rodriguez-Becerra. Polimorfismos del gen de la COX-2 y celularidad del LBA de la sarcoidosis Archivos de Bronconeumología 2010; 46: Especial Congreso: 171.
  • López FJ, Martínez C, Rego C, Fernández E, Castro P. Elevación de marcadores de inflamación y estrés oxidativo en una población de trabajadores expuestos a polvo de sílice y su relación con la aparición de neumoconiosis. Archivos de Bronconeumologia 2009; 45 (especial congreso): 106.
  • Ragull S, Ruiz J, Morera J, Lane K, Roldan J. Mecanismos genéticos y celulares en fibrosis pulmonar. Archivos de Bronconeumologia 2009; 45 (especial congreso) 156.
  • A Xaubet, J Ancochea, J Villar, JJ Gómez (Coordinadores). Consenso para el diagnóstico de las neumonías intersticiales idiopáticas (SEPAR, SEICAT, SEAP). Archivos de Bronconeumología 2010; 46: Extraordinario 5. 
  • López FJ, Martínez C, Rego C, Fernández E, Castro P. Elevación de marcadores de inflamación y estrés oxidativo en una población de trabajadores expuestos a polvo de sílice y su relación con la aparición de neumoconiosis. Archivos de Bronconeumologia 2009; 45 (especial congreso): 106 
  • Íñigo Royo Crespo, Juan José Fibla Alfara, Laureano Molins López-Rodó, Primitivo Martínez Vallina, Santiago García Barajas, Ana Gómez, Miriam Estors, Emili Canalís, Ana Blanco, Milagros Moldes, Néstor Martínez, Antonio Arnau, Esther Fernández, Ángel Carvajal, Pablo León Atance, Pedro Rodríguez, Jorge Freixinet Gilart. . Resultados del papel de la biopsia pulmonar videotoracoscópica en el diagnóstico de la enfermedad pulmonar intersticial difusa y evaluación de un abordaje quirúrgico ambulatorio dentro del programa de investigación integrada sobre EPID Abstract remitido al Congreso Nacional SEPAR 2009. Archivos de Bronconeumologia 2009; 45(especial congreso): 157.
  • Lymphangioleiomyomatosis: a study of 72 patients from the Spanish Register. Esther Antón, Álvaro Casanova, Antoni Xaubet Antoni Román, Victoria Villena, Mª Carmen Montero, María Molina-Molina, Elvira Pérez- Sánchez, Antonio Sueiro, Ferrán Morell, Rosa Mª Girón, Julio Ancochea... Sarcoidosis Vasc Diffuse Lung Dis; 2009; 26: 85-91. 
  • López-Campos JL, Rodríguez-Rodriguez D, Rodriguez-Becerra E, Alfageme I, Fernández J., García FJ, Casanova A, Fernández de Córdoba J, Romero-Ortiz A, Arellano-Orden E, Montes-Worboys A. Cyclooxygenase-2 polymorphisms confers susceptibility to sarcoidosis but are not related to prognosis. Resp. Med., 2009; 427-433 
  • Factores predictores de supervivencia en pacientes con fibrosis pulmonar idiopática Álvaro Casanova, Rosa Mª Girón, María Molina Antoni Xaubet, Julio Ancochea. Med Clin (Barc). 2009; 133: 333-336.  
  • A Baloira, A Xaubet, E Rodríguez-Becerra, AD Romero, A Casanova, J Ancochea. Neumonía intersticial descamativa y bronquiolitis respiratoria asociada a enfermedad pulmonar intersticial. Datos del registro español. Archivos de Bronconeumología. 2008; 44: 499-503.
  • M Molina-Molina, A Xaubet, X Li, A Abdul- Hafez, K Friderici, K Jeringan, W Fu, Q Ding, J Pereda, A Serrano-Mollar, A Casanova, E Rodríguez-Becerra, F Morell, J Ancochea, C Picado, BD Uhal Angiotensin gen G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression Eur Resp J 2008; 32: 1004-1008 
  • X Li, M Molina-Molina, A Abdul- Hafez, V Uhal, A Xaubet, BD Uhal. Angiotensin converting enzyme-2 is protective but downregulates in human and experimental lung fibrosis. Am, J, Physiol. Lung Cell Mol. Physiol 2008; 295: L 178- L 185 
  • Luis López-Campos JL, Rodríguez-Rodríguez D, Rodríguez-Becerra E, Alfageme Michavila I, Fernández Guerra J, García Hernández FJ, Casanova A, Fernández de Córdoba Gamero J, Romero Ortiz A, Arellano-Orden E Montes-Worboys A Association of the 3050G>C polymorphism in the cyclooxygenase-2 gene with systemic sarcoidosis. Arch Med Res 2008; 39: 525-530. 
  • Mata Calderón P, López-Campos Bodineau JL, Rodríguez Rodríguez D, Rodríguez Becerra E, Alfageme Michavila, Fernández Guerra J, García Hernández FJ, Casanova A, Fernández de Córdoba Gamero J, Romero Ortiz A, Arellano Orden E, Montes Worboys A. Los polimorfismos de la ciclooxigenasa 2 están relacionados con la susceptibilidad pero no con el pronóstico de la sarcoidosis. 41º Congreso SEPAR. Tenerife, junio 2008. 
  • Rojano Broz B, López-Campos JL, Rodríguez Rodríguez D, Rodríguez Becerra E, Alfageme Michavila I, Fernández Guerra J, García Hernández FJ, Casanova A, Fernández de Córdoba J, Romero Ortiz A, Arellano Orden E, Montes Worboys A, Asensio Cruz, MI. Polimorfismos del gen de la ciclooxigenasa 2 y celularidad del lavado broncoalveolar de la sarcoidosis. 41º Congreso SEPAR. Tenerife, junio 2008. 
  • JL Lopez-Campos, D Rodriguez-Rodriguez, E Rodriguez-Becerra, I Alfageme Michavila, J Fernandez Guerra, FJ Garcia Hernandez, A Casanova, J Fernandez de Cordoba, A Romero-Ruiz, E Arellano-Orden, A Montes Worboys. Changes in bronchoalveolar lavage cell profile according to cyclooxigenase 2. polymorphism. Am J Respir Crit Care Med 2008; 177(Abstract issue): A551. 
  • D Rodriguez-Rodriguez, JL Lopez-Campos, E Rodriguez-Becerra, I Alfageme Michavila, J Fernandez Guerra, FJ Garcia Hernandez, A Casanova, J Fernandez de Cordoba, A Romero-Ruiz, E Arellano-Orden, A Montes Worboys. Cyclooxygenase-2 polymorphisms: susceptibility and prognosis of sarcoidosis. Am J Respir Crit Care Med 2008; 177(Abstract issue): A552. 
  • L. Molins, J.J. Fibla, J.M. Mier, A.M. Sierra Videothoracoscopic lung biopsy (VATS-LB) in the diagnosis of diffuse interstitial lung disease (DILD) and evaluation of an outpatient surgical approach. A prospective multicentric study L. Molins, J.J. Fibla, J.M. Mier, A.M. Sierra. Congreso ERS 2008. Thematic Poster Session.
  • M Molina-Molina, BD Uhal, X Li, A Abdul-Hafez, K Frederici, W Fu, J Pereda, J Ancochea, C Picado, A Xaubet. Angiotensin gen G-6ª polymorphism influences disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2008; 177: A889.
  • J Ramirez, A Xaubet, J Pereda, BD Uhal, X Li, M Molina-Molina. Angiotensin II antagonism inhibits collagen deposition in idiopathic pulmonary fibrosis. Modern Pathology 2008; 21: 349A.
  • Mata Calderon P, Lopez-Campos JL, Rodriguez Rodriguez D, Rodriguez Becerra E, Alfageme Michavila I, Fernandez Guerra J, Garcia Hernandez FJ, Casanova. A. Los polimorfismos de la ciclooxigenasa 2 están relacionados con la susceptibilidad pero no con el pronóstico de la sarcoidosis XXXIV Congreso NEUMOSUR. Jaen, Marzo 2008.
  • Lopez-Campos JL, Rodriguez Rodriguez D, Rodriguez Becerra E, Alfageme Michavila, Fernandez Guerra J, Garcia Hernandez FJ, Casanova, A, Fernandez de Cordoba J, Romero Ortiz A, Arellano Orden E, Montes Worboys A. Importancia de los polimorfismos de la ciclooxigenasa 2 en la presentación clínica de la sarcoidosis.XXXIV Congreso NEUMOSUR. Jaen, marzo 2008.
  • Molins L, Fibla JJ, Mier JM, Sierra A. Outpatient thoracic surgery. Thoracic Surgery Clinics 2008;18:321-327.
  • X. Li, M. Molina-Molina, A. Abdul-Hafez, J. Ramirez, A Serrano-Mollar, A. Xaubet, B. Uhal Extravascular sources of lung angiotensin peptide sybthesis in idiopathic pulmonary fibrosis Am. J. Physiol. Lung Cell. Mol. Physiol. 2006; 291: L 887- L 895.
  • J. Pereda, M. Molina.Molina, A. Xaubet, O. Bulbena, A. Serrano-Mollar Papel de los receptores nucleares PPARA y PPARG en el desarrollo de as fibrosis pulmonar idiopática. Archivos de Bronconeumología 2006; 42 Especial congreso; 126.
  •  A. Xaubet, A. Serrano .Mollar, J. Ancochea, M. Molina-Molina, J. Pereda, A Casanova, F Morell, JM. Rodríguez Arias, E Rodríguez Becerra, V Villena, J Flandes. Polimorfismos del gen de la ciclooxigenasa-2 en la fibrosis pulmonar idiopática. Archivos de Bronconeumologia 2007; 43 (Especial Congreso); 112.